Skip to content

Effect of kulakadi formulation and dooshivishari tablet along with external application of satadhouta ointment in the management of chronic allergic skin rashes

Effect of kulakadi kashaya and dooshivishari agada along with external application of satadhouta ghrita in the management of chronic urticaria - nil

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/054980
Enrollment
24
Registered
2023-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L508- Other urticaria

Interventions

None listed

Sponsors

Government Ayurveda College Panchakarma Hospital Poojappura campus Thiruvananthapuram
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Participants with chronic urticaria defined as urticarial eruption for more than 6 week duration. 2 Both male and female participants between the age group of 18-60 presenting with complaints of wheals(less than 50 number) along with any one of the signs and symptoms -pruritis /Discoloration(pale/red/ pink)/Angioedema with out the involvement of airway obstruction

Exclusion criteria

Exclusion criteria: 1 Participants on continuous allopathic medications for urticaria 2 Participants having history of anaphylasis and urticarial vasculitis 3 Pregnant ladies and lactating mother. 4 Participants having drug allergy 5 Participants with uncontrolled systemic illness

Design outcomes

Primary

MeasureTime frame
Based on Urticaria Activity Score(UAS7); Wheals & Pruritis Timepoint: 0th-6th consecutive days 39th-45th consecutive days 53rd-59th consecutive days

Secondary

MeasureTime frame
Chronic Urticaria quality of Life Questionaire(CU-Q2oL)-quality of life Erythema(discolouration) Timepoint: 0th day,46th day & 60th day

Countries

India

Contacts

Public ContactDr Seemaja G

Government Ayurveda college, Thiruvananthapuram

drseemaja@gmail.com09447004418

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026